Publikationen, an denen er mitarbeitet Foivos Sokratis Lazaris (13)

2024

  1. Development of unnatural glycopeptides based on Mucin-1 with diagnostic and therapeutic potential

    6th Regular Network Meeting of the DIRNANO consortium in Salzburg

  2. Non-natural MUC1 Glycopeptide Homogeneous Cancer Vaccine with Enhanced Immunogenicity and Therapeutic Activity

    XXIX RSEQ Biennial Meeting in Organic Chemistry: Santa Cruz de Tenerife, June 26-28, 2024: Abstract Book

  3. Non‐natural MUC1 Glycopeptide Homogeneous Cancer Vaccine with Enhanced Immunogenicity and Therapeutic Activity

    Angewandte Chemie International Edition

  4. Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses

    JACS Au, Vol. 4, Núm. 1, pp. 150-163

2023

  1. Evaluation of the immunostimulant properties of carbon dot nanoparticles as carriers for cancer vaccines

    XXXIX Reunión Bienal de Química RSEQ

  2. Evaluation of the immunostimulant properties of carbon dot nanoparticles as self-adjuvating cancer vaccines

    Jornadas Posdoctorales Campus Iberus Postdoctoral Days

  3. Impact of structure-guided cancer nano-vaccine candidates and their respective nanoformulations in preclinical cancer models

    3rd Regular Meeting of the DIRNANO consortium

  4. Impact of structure-guided cancer nano-vaccine candidates and their respective nanoformulations in preclinical cancer models & biosensor development

    5th Regular Meeting of the DIRNANO consortium

  5. Methyl-to-Ethyl Replacement Makes the Difference: Structure-Guided Design of a New Cancer Vaccine Based on a Tn An-gen Surrogate

    VI RSEQ Chemical Biology Group Meeting - ChemBio VI

  6. Structure-guided design of unnatural Mucin-1 biomimetics for the development of cancer therapeutic nano-vaccines and diagnostic assays

    4th Regular Meeting of the DIRNANO consortium

2022

  1. Directing the immune response through designed nanomaterial. Winter School Presentation

    Winter School of the DIRNANO consortium

  2. Directing the immune response through designed nanomaterials. Progress Report

    1st Regular Meeting of the DIRNANO consortium

  3. Innovative cancer nano-vaccine based on a MUC1-like glycopeptide comprising unnatural amino acids

    XXXVIII Reunión Bienal de la Real Sociedad Española de Química - RSEQ 2022 (Abstracts book)